Education
About Us
Working with TipRanks
Follow Us
Lemaitre Vascular (LMAT)
:LMAT
LMAT Stock Chart & Stats
$87.26
$0.87(0.94%)
At close: 4:00 PM EST
$87.26
$0.87(0.94%)
Day’s Range― - ―
52-Week Range$71.42 - $109.58
Previous CloseN/A
Volume40.91K
Average Volume (3M)131.07K
Market Cap
$1.95B
Enterprise ValueN/A
Total Cash (Recent Filing)$343.06M
Total Debt (Recent Filing)$185.63M
Price to Earnings (P/E)41.9
Beta0.86
Next Earnings
Feb 19, 2026EPS Estimate
0.66Last Dividend Ex-Date
Nov 20, 2025Dividend Yield0.92%
Share Statistics
EPS (TTM)0.75
Shares Outstanding22,637,522
10 Day Avg. Volume144,773
30 Day Avg. Volume131,073
Financial Highlights & Ratios
PEG Ratio1.06
Price to Book (P/B)6.13
Price to Sales (P/S)9.41
P/FCF Ratio55.67
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$98.75Price Target Upside13.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Cash FlowFree cash flow in the quarter was very strong, significantly exceeding the estimate, highlighting robust cash generation.
Earnings PerformanceAdjusted EPS of $0.62 solidly beat both the estimate and the consensus expectation, indicating strong earnings performance.
Top-Line GrowthLeMaitre continues to deliver double-digit organic top-line growth with material margin expansion and strong cash flows and, as such, deserves the premium valuation most investors are affording it.
Bears Say
Lemaitre Vascular News
LMAT FAQ
What was Lemaitre Vascular’s price range in the past 12 months?
Lemaitre Vascular lowest stock price was $71.42 and its highest was $109.58 in the past 12 months.
What is Lemaitre Vascular’s market cap?
Lemaitre Vascular’s market cap is $1.95B.
When is Lemaitre Vascular’s upcoming earnings report date?
Lemaitre Vascular’s upcoming earnings report date is Feb 19, 2026 which is in 90 days.
How were Lemaitre Vascular’s earnings last quarter?
Lemaitre Vascular released its earnings results on Nov 06, 2025. The company reported $0.75 earnings per share for the quarter, beating the consensus estimate of $0.566 by $0.184.
Is Lemaitre Vascular overvalued?
According to Wall Street analysts Lemaitre Vascular’s price is currently Undervalued.
Does Lemaitre Vascular pay dividends?
Lemaitre Vascular pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 0.92%. See more information on Lemaitre Vascular dividends here
What is Lemaitre Vascular’s EPS estimate?
Lemaitre Vascular’s EPS estimate is 0.66.
How many shares outstanding does Lemaitre Vascular have?
Lemaitre Vascular has 22,637,522 shares outstanding.
What happened to Lemaitre Vascular’s price movement after its last earnings report?
Lemaitre Vascular reported an EPS of $0.75 in its last earnings report, beating expectations of $0.566. Following the earnings report the stock price went up 1.425%.
Which hedge fund is a major shareholder of Lemaitre Vascular?
Currently, no hedge funds are holding shares in LMAT
Lemaitre Vascular Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$98.75 (13.17% Upside)
$98.75 (13.17% Upside)
Blogger Sentiment
Bullish
LMAT Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 147.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.2%
Last 30 Days ▲ 6.3%
Last 30 Days ▲ 6.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.12%
12-Months-Change
Fundamentals
Return on Equity
15.02%
Trailing 12-Months
Asset Growth
59.08%
Trailing 12-Months
Company Description
Lemaitre Vascular
Lemaitre Vascular (LMAT) is a medical device company that specializes in the development, manufacturing, and marketing of products for the treatment of vascular diseases. The company primarily focuses on peripheral vascular surgery and offers a range of products including vascular grafts, stent grafts, and other related surgical devices. With a commitment to innovation, Lemaitre Vascular aims to improve patient outcomes through its advanced technologies and products designed for the treatment of various vascular conditions.
LMAT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. LeMaitre Vascular reported strong organic sales growth, international expansion success, and improved gross margins, but faced challenges related to a catheter recall, struggles in the APAC region, and a lowered revenue guidance due to FX changes. The sentiment is balanced with positive achievements and notable challenges.View all LMAT earnings summariesLMAT Stock 12 Month Forecast
Average Price Target
$98.75
▲(13.17% Upside)
Technical Analysis
Ownership Overview
7.88% Insiders
24.18% Mutual Funds
31.95% Other Institutional Investors
11.62% Public Companies and
Individual Investors